NCT04191499 2026-03-17
INAVO120
Hoffmann-La Roche
Phase 2/3 Active not recruiting
Clinical Trials
9 trialsNCT06062810 2026-03-09
Drugs-SNPs
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT04290793 2026-01-07
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2/3 Active not recruiting
NCT05747794 2024-12-17
AIPAC-003
Immutep S.A.S.
Phase 2/3 Active not recruiting
NCT05889390 2024-12-03
NeoHTerMa
Semmelweis University
Phase 2/3 Active not recruiting
NCT03315364 2024-07-25
OPTIMAL
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3 Active not recruiting
NCT02641847 2024-01-25
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
Fudan University
Phase 2/3 Active not recruiting
NCT01057069 2022-10-12
neo-TN
The Netherlands Cancer Institute
Phase 2/3 Active not recruiting
NCT02568839 2020-08-13
PREDIX HER2
Karolinska University Hospital
Phase 2/3 Active not recruiting